Work

Use of PER977 to Reverse the Anticoagulant Effect of Edoxaban

Year: 2014

Type: article

Abstract: Among 80 healthy persons who had received a single dose of edoxaban, the whole-blood clotting time was reduced significantly more rapidly in those who received the novel small molecule PER977 than in controls who were not given PER977.

Source: New England Journal of Medicine

DOI: 10.1056/nejmc1411800

Authors: Jack E. Ansell, Sasha H. Bakhru, Bryan E. Laulicht, Solomon S. Steiner, Michael Grosso, Karen Brown, Victor Dishy, Robert J. Noveck, James C. Costin

Institution: Hofstra University

Language: English

Topic: Blood Coagulation and Thrombosis Mechanisms

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2065193471

FWCI: 56.07

Cites: 2

Cited by: 420

Related to: 10